Target intelligence / Profile preview

Single-pass membrane protein with aspartate-rich tail 1 (essential MCU regulator) (SMDT1)

Target
SMDT1
Molecular classification
Other (essential regulatory subunit), Ion channel auxiliary protein (component of mitochondrial calcium uniporter complex)
01

Overview

SMDT1 (Single-pass membrane protein with aspartate-rich tail 1; commonly known as EMRE) is the essential regulatory subunit of the mitochondrial calcium uniporter (MCU) complex, a multi-protein channel required for calcium uptake into the mitochondrial matrix[1][2][3][4]. EMRE/SMDT1 is a small (~11 kDa), single-pass transmembrane protein localized to the inner mitochondrial membrane. Its structure includes an acidic tail exposed to the mitochondrial matrix, acting as a calcium sensor[2]. EMRE is indispensable in linking the pore-forming MCU to its regulatory calcium-sensing proteins (MICU1, MICU2), ensuring tight regulation of channel activity in response to calcium signaling[1][2][3][4]. EMRE stabilizes the MCU complex, acts as a molecular scaffold, and maintains the channel in the open state under appropriate conditions[3][4]. Pathogenic mutations or imbalances in EMRE expression have been associated with disorders of mitochondrial function and calcium homeostasis, including neurological disease[1][2]. There are no known therapeutic agents or biomarkers that specifically target SMDT1/EMRE, but its central regulatory role establishes it as a potential target in diseases involving mitochondrial calcium dysregulation.

Other names
EMREEssential MCU regulator, mitochondrialC22orf32DDDDUPF0466 protein C22orf32dJ186O1.1essential MCU regulator, mitochondrialsingle-pass membrane protein with aspartate-rich tail 1, mitochondrial
02

Biological functions

Mitochondrial calcium uptake regulationCalcium signalingMitochondrial homeostasis
03

Disease associations

Neurological disorders (e.g., spastic ataxia 5)Other (mitochondrial calcium dysregulation-related pathologies)
04

Safety considerations

Mitochondrial calcium overload or deficiency (theoretical safety concern from dysregulation)Potential neurotoxicity or myopathy if dysregulated

Beyond the preview

Go deeper on Single-pass membrane protein with aspartate-rich tail 1 (essential MCU regulator) (SMDT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Single-pass membrane protein with aspartate-rich tail 1 (essential MCU regulator) (SMDT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call